These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17657174)

  • 1. A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer.
    Goldman ML; Denduluri N; Berman AW; Sausville R; Guadagnini JP; Kleiner DE; Brahim JS; Swain SM
    Oncology; 2006; 71(3-4):306-8. PubMed ID: 17657174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis of the Torus Palatinus in the Setting of Long-Term Oral Bisphosphonate Use--A Case Report.
    Ryan JL; Larson E
    S D Med; 2016 Jan; 69(1):23-5. PubMed ID: 26882578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avascular osteonecrosis of the mandible following bisphosphonate therapy.
    Chandra PA; Chandra AB; Todd GK
    Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
    Mignogna MD; Fedele S; Lo Russo L; Ciccarelli R; Lo Muzio L
    J Clin Oncol; 2006 Mar; 24(9):1475-7. PubMed ID: 16549843
    [No Abstract]   [Full Text] [Related]  

  • 6. Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis.
    Flores IL; dos Santos-Silva AR; Della Coletta R; Vargas PA; Lopes MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):e264-8. PubMed ID: 24528798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
    Leite AF; Figueiredo PT; Melo NS; Acevedo AC; Cavalcanti MG; Paula LM; Paula AP; Guerra EN
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):14-21. PubMed ID: 16831667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
    Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
    Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
    Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
    Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA; Schubert MM; Peterson DE; Seneda LM
    Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates.
    DE Iuliis F; Taglieri L; Amoroso L; Vendittozzi S; Blasi L; Salerno G; Lanza R; Scarpa S
    Anticancer Res; 2014 May; 34(5):2477-80. PubMed ID: 24778063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.
    Nastro E; Musolino C; Allegra A; Oteri G; Cicciù M; Alonci A; Quartarone E; Alati C; De Ponte FS
    Acta Haematol; 2007; 117(3):181-7. PubMed ID: 17164581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab.
    Francini F; Pascucci A; Francini E; Miano ST; Bargagli G; Ruggiero G; Petrioli R
    J Am Dent Assoc; 2011 May; 142(5):506-13. PubMed ID: 21531932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
    Van Poznak C
    Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
    Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.